Filtered By:
Condition: Nephrotic Syndrome
Procedure: Transplants

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2562 results found since Jan 2013.

Comparison of clinical features of nephrotic syndrome after haploidentical and matched donor hematopoietic stem cell transplantation
Chin Med J (Engl). 2023 Aug 28. doi: 10.1097/CM9.0000000000002795. Online ahead of print.NO ABSTRACTPMID:37640669 | DOI:10.1097/CM9.0000000000002795
Source: Chinese Medical Journal - August 28, 2023 Category: General Medicine Authors: Wei Sun Yuanyuan Zhang Yuhong Chen Yuqian Sun Yifei Cheng Fengrong Wang Huan Chen Yao Chen Chenhua Yan Xiaodong Mo Wei Han Lanping Xu Yu Wang Xiaohui Zhang Kaiyan Liu Xiaojun Huang Source Type: research

Recurrent Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Survival
CONCLUSIONS The MPGN recurrence rate was 25%, most of them recipients of kidneys from living donors. Nephrotic syndrome and C3 consumption were frequent at recurrence. The graft function was similar between the groups, and the 5-year graft survival rate in the recurrence group was higher than in other studies.PMID:37461201 | PMC:PMC10362803 | DOI:10.12659/AOT.940502
Source: Annals of Transplantation - July 18, 2023 Category: Transplant Surgery Authors: Lais Ceccatto de Paula Marilda Mazzali Marcos Vinicius de Sousa Source Type: research

Role of cyclosporin A in the treatment of kidney disease and nephrotoxicity
Toxicology. 2023 May 8:153544. doi: 10.1016/j.tox.2023.153544. Online ahead of print.ABSTRACTThe clinical use of cyclosporin A (CsA) has led to significant advances and achievements in the field of transplantation and immune diseases. However, the nephrotoxicity of CsA is a major concern in current immunosuppression regimens. CsA causes abnormal kidney function while treating kidney disease, causing problems for clinicians and patients. Evidence of CsA nephrotoxicity is almost always present in transplant recipients after long-term CsA administration (up to 10 years), and similar phenomena occur with other calcineurin inhi...
Source: Toxicology - May 10, 2023 Category: Toxicology Authors: Jun Yu Xiao Wei Jinzhang Gao Chun Wang Wei Wei Source Type: research